- Home
- KMDA vs LNKB Comparison
KMDA vs LNKB Comparison
Compare KMDA & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- LNKB
- Stock Information
- Founded
- KMDA 1990
- LNKB 2018
- Country
- KMDA Israel
- LNKB United States
- Employees
- KMDA N/A
- LNKB N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- LNKB
- Sector
- KMDA Health Care
- LNKB
- Exchange
- KMDA Nasdaq
- LNKB Nasdaq
- Market Cap
- KMDA 394.4M
- LNKB 284.4M
- IPO Year
- KMDA N/A
- LNKB N/A
- Fundamental
- Price
- KMDA $6.92
- LNKB $7.23
- Analyst Decision
- KMDA Strong Buy
- LNKB Buy
- Analyst Count
- KMDA 2
- LNKB 2
- Target Price
- KMDA $14.50
- LNKB $8.25
- AVG Volume (30 Days)
- KMDA 159.8K
- LNKB 35.3K
- Earning Date
- KMDA 03-05-2025
- LNKB 01-27-2025
- Dividend Yield
- KMDA N/A
- LNKB 4.22%
- EPS Growth
- KMDA 124.29
- LNKB N/A
- EPS
- KMDA 0.27
- LNKB 0.71
- Revenue
- KMDA $158,380,000.00
- LNKB $108,499,000.00
- Revenue This Year
- KMDA $15.37
- LNKB N/A
- Revenue Next Year
- KMDA $8.58
- LNKB $3.82
- P/E Ratio
- KMDA $25.36
- LNKB $10.02
- Revenue Growth
- KMDA 4.52
- LNKB 255.70
- 52 Week Low
- KMDA $4.74
- LNKB $5.86
- 52 Week High
- KMDA $8.00
- LNKB $7.98
- Technical
- Relative Strength Index (RSI)
- KMDA 50.80
- LNKB 46.03
- Support Level
- KMDA $6.90
- LNKB $7.02
- Resistance Level
- KMDA $7.56
- LNKB $7.25
- Average True Range (ATR)
- KMDA 0.19
- LNKB 0.20
- MACD
- KMDA -0.09
- LNKB -0.00
- Stochastic Oscillator
- KMDA 15.95
- LNKB 41.79
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.